Cysteamine Market to Grow at 6.5% CAGR Through 2031, Driven by Rare Disease Therapies and Emerging Market Expansion – Says The Insight Partners
According to a new market study published by The Insight Partners, titled “Cysteamine Market Forecast to 2031 – Global Analysis – by Type, Application, End Use, and Geography,” the market is projected to grow at a CAGR of 6.5% from 2025 to 2031. The market growth is driven by increased adoption of cysteamine in treating rare diseases, regulatory approvals for new...
0 Comentários 0 Compartilhamentos 49 Visualizações